Medical experts have long accepted internal bleeding as a serious and potentially life-threatening condition that has been known to have a high mortality rate. To demonstrate the seriousness of the condition, the recent cases of patients who were into the anticoagulant Xarelto for the treatment of certain disorders would be good examples. Due to the uncontrolled bleeding, these patients, who were later diagnosed to be suffering from intracranial hemorrhage and gastrointestinal bleeding, had to be taken to the hospital for emergency medical treatment. Reports have it that new anticoagulants like Xarelto increase risk of gastrointestinal bleeding and many of these patients have sought assistance in the filing of Xarelto lawsuits for the possible compensation of the harm they endured.
Here are brief descriptions of gastrointestinal bleeding and intracranial hemorrhage for those who may not be too acquainted with these bleeding complications and who may be taking Xarelto at the moment.
Acknowledged by medical experts as serious and potentially life-threatening, gastrointestinal bleeding may be defined as any bleeding that may start from the gastrointestinal tract. When the affected parts are in the upper tract, consisting of the esophagus, stomach, and the first part of the small intestines, this is classified as upper gastrointestinal bleeding. Any bleeding that may have developed from the rectum, anus, small intestines, and large intestines is considered as lower gastrointestinal bleeding.
Visible symptoms of gastrointestinal bleeding may include dark, tarry-looking stools; small quantities of blood in the toilet paper, toilet seat, or feces; vomiting of blood; and possibly blood passing through the rectum. For a number of cases, it is only after a laboratory examination such as the fecal occult blood test or through the use of medical apparatuses that bleeding may be detected, especially if this involves small quantities.
A very serious and fatal condition, intracranial hemorrhage or intracranial hematoma may be described as bleeding occurring inside the cranium. A blood vessel found in between the skull and the brain that may have ruptured is the usual cause for this type of bleeding. Compression of the brain tissues or deprivation of blood supply may result when there is an increase in the intracranial pressure brought about by the buildup of blood in the skull. Brain damage or even death may result when either of the two occurs.
There are three types of intracranial hemorrhage, classified according to the location of the bleeding. When the blood vessels burst between the brain and the outermost of the membrane layers that cover the brain, this is called subdural hematoma. Subarachnoid hemorrhage would be the diagnosis if the bleeding is into the cerebrospinal fluid or the CSF. The diagnosis would be intraparenchymal hematoma when the blood pools in the brain. The more common symptoms would be increased pressure inside the skull, sudden severe headache, vomiting, weakness, numbness and impaired functions, although there may also be other symptoms depending on the patient.
In just a span of four days, two verdicts in the continuing bladder mesh litigation were returned by juries finding the mesh manufacturers involved in these controversies as liable for the injuries sustained by the complainants and ordered to pay damages. These developments are certainly very encouraging to the thousands of women who have filed bladder mesh lawsuits in the hope of recovering their losses as a result of the complications attributed to these mesh implants. These victories may even persuade mesh manufacturers to decide on a settlement of the claims. You may learn more about bladder mesh settlement by checking www.bladdermeshlawsuitcenter.com/settlements/.
According to a report from an online media sources, a jury in a federal court in West Virginia rendered a decision on September 5, 2014 finding Ethicon Inc., a subsidiary of the health care giant Johnson & Johnson, responsible for the injuries sustained by Jo Huskey. The plaintiff was implanted with a GYNECARE TVT-O bladder sling on February 23, 2011 for the treatment of her stress urinary incontinence (SUI). In just a few months after her sling procedure in an Illinois medical facility, she started experiencing severe complications that included mesh extrusion, pelvic and groin pain, serious infections, mesh shrinkage, urinary problems, vaginal bleeding, and dyspareunia or painful sexual intercourse.
After hearing testimonies for a period of two weeks, an eight-member jury serving for the US District Court for Southern District of West Virginia handed down a decision favoring the complainant. In resolving the case, the jury believed that the GYNECARE TVT-O bladder sling that was implanted on Jo Huskey was defectively designed and the Ethicon failed to provide adequate warnings to patients and healthcare providers of the risks associated with the vaginal mesh device. Since it was earlier ruled that no punitive damages will be given, Jo Huskey was only awarded compensatory damages totaling $3.27 million.
On September 8, 2014, exactly three days after the Ethicon loss in West Virginia, another jury in Texas gave Boston Scientific its first loss when it found the Massachusetts-based mesh company responsible for the harm suffered by Martha Salazar. Like Jo Huskey, Martha Salazar also suffered from SUI and for this pelvic floor disorder she underwent a sling procedure using Boston Scientific’s Obtryx Transobturator Mid-Urethral Sling (MUS) system. Due to the bladder sling implanted, Miss Salazar suffered complications such as mesh erosion, terrible infections, irreversible nerve damage, pelvic and groin pain, and dyspareunia.
At the conclusion of the trial, the jury came up with a decision finding Boston Scientific answerable for the serious and permanent injuries suffered by Martha Salazar. Boston Scientific was found guilty for manufacturing a vaginal mesh device that was defectively designed and for failing to warn doctors and patients of the complications associated with the Obtryx Tranobturator MUS system. For the losses incurred by the claimant, the jury awarded compensatory damages amounting to $23.5 million. And since the panel believed that there was gross negligence on the part of Boston Scientific, punitive damages of $50 million was likewise included.
These twin victories have been very much welcomed by other mesh victims whose vaginal mesh lawsuits are pending in different courts. These developments become even more significant considering the unfavorable decisions of two earlier Boston Scientific lawsuits held in Massachusetts. Many are hoping that these victories of mesh victims will prod mesh manufactures to decide on a lawsuit settlement.
Over 500 Avaulta mesh lawsuits pending in several state and federal courts have been settled by C.R. Bard, according to a recent report from an online media source. It was clarified that the early settlements made by the company, including a mesh claim that was supposed to go to trial in May 2014 as part of the multidistrict litigation (MDL) in West Virginia, were not part of these latest settlements.
This information was contained in the quarterly report of C.R. Bard that was submitted on July 25, 2014 to the Securities and Exchange Commission (SEC). In the same report, it was revealed that the company and representatives of the plaintiffs are currently having negotiations for a possible Avaulta mesh lawsuits settlements.
At the moment, the total number of Avaulta mesh lawsuits has been placed at over 12,500 which are pending in different courts across the country. It was only after patients allegedly experienced severe complications after being implanted with Avaulta vaginal mesh for the repair of their pelvic floor disorders that these lawsuits started to be filed by injured women. Women have described as horrific and devastating the pain and suffering they have to endure, according to their accounts that may be found in http://avaultavaginalmeshlawsuit.blog.com
and other related sites.
One of the best options in managing such is a total hip replacement, which can be easily resorted to if the patient can survive the conditions of the procedure. However, hip surgeries may be dangerous due to safety issues of hip prostheses just like the recalled Smith and Nephew R3 Acetabular System and Metal Liner. With this, affected patients filed Smith and Nephew lawsuit against the company.
Even before the Smith and Nephew hip recall in June 2012, the Food and Drug Administration (FDA) already received various negative feedbacks about the hip devices. Legal professionals say that several clients have initiated court actions against Smith and Nephew.
The presence of microscopic metal parts in the circulatory system because of the metal components rubbing against each other (and flaking off) may have risen from the design problems associated with metal-on-metal hip implant devices, like the Smith and Nephew. Furthermore, tumors and cancer may also arise because of cobalt and chromium in the patient’s blood.
All medical manufacturing companies should guarantee the safety of their products and the Smith and Nephew hip replacement recall should be a clear wake-up call for them to immediately act on the issues of their products, legal observers say.
Minimally invasive techniques have all the difference in performing hysterectomies and other gynecological procedures. There are still some difficulties,though, that encountered by surgeons, medical health experts say. The Da Vinci Surgical System also uses the same idea and technology used in laparoscopic surgery, according to the Da Vinci Surgery website, but is more precise, dexterous and offers better vision. Thus, with all the advances in the field of surgery, one might think that robotic-assisted gynecological operations will create better results when compared to open and traditional laparoscopic procedures. Hospitals may offer open, laparoscopic or robotic-assisted hysterectomy and patients are free to discuss whichever procedure they are comfortable with together with her surgeon.
The long incisions that used to dominate hysterectomies may now be avoided because of robotic assistants. The surgical removal of the uterus and other components is often indicated when there are fibroids, endometriosis and adenomyosis, cervical and uterine cancer, and abnormal excessive bleeding. Open abdominal hysterectomy may require the woman to stay in the hospital between three to five days while laparoscopic hysterectomy only requires the patient an overnight stay in the hospital. A two-month recovery time ma y be expected when undergoing an open adnominal hysterectomy whereas minimally invasive hysterectomy may allow women to go back to their work within two to four weeks post-operation.
On the other hand, robotically-assisted hysterectomy may be similar to that of the laparoscopic procedure in terms of recovery time. The difference is the efficacy on how the surgeon performs the operation. The three-dimensional view offered by the camera in the robotic system allows the surgeon to see much better than when using the two-dimensional camera in traditional laparoscopic procedure. Complicated hysterectomies that are not easily performed using the traditional approach in laparoscopic surgery may now be easier for surgeons.
However, there are several Da Vinci lawsuits that were filed after patients underwent surgery using the robotic assistant. The Food and Drug Administration keeps a close watch of all the operations performed using the robotic surgical system to pinpoint where the problem lies. Patients may ask their surgeon for all available options before deciding regarding their surgery.
Issues are stirring amongst investors after the release of Merck’s quarterly sales report, in which revenue of its best-selling diabetes drug Januvia dropped by 2 percent, writer max Chatsko says. Investors are now seeing a couple of red flags regarding the company’s franchise for treating type 2 diabetes, specifically Januvia and Janumet, according to the Motley Fool website. Januvia is one of Merck’s successful diabetes drugs that brought the company billions of sales profit since 2011 through 2012.
Although the slide of 2 percent may seem not much to be worried about, Januvia ended a growth of 18 percent in 2012, showing a double growth almost every quarter. However, writer Chatsko explained that the data was out very early, thus the results are still inconclusive and unpredictable. He added that Merck should be watchful for Januvia’s so called “red flags”, biggest contributing factors for its downfall.
Overall, problems of Januvia causing pancreatitis that were resulting to Januvia lawsuits along with a couple of newly approved FDA diabetes medications from other competitors are probable reasons of its drop in sales percentage.
Even though investors are inconclusive as of the moment, this is definitely something to watch moving forward.
What usually alarms the recipients of defective hip implants is the development of metallosis, which is commonly known as metal poisoning, medical experts say. Unfortunately, this complication from metal-on-metal devices has been associated with DePuy Orthopaedic, a business unit of Johnson and Johnson.In fact, metallosis is mentioned prominently in the present batch of 8,000 lawsuits filed against the company. There are compensatory damage claims that were being filed amid allegations of metallosis and the risks it bring to the men and women who have them.
Metallosis is a form of metal poisoning triggered by the increase of number of tiny metal particles being shred off artificial hip devices. Because these metallic shards slip into the blood stream, it has become a common side effect of some metal-on-metal hip implants which wear down in the body and leave behind metal shavings.
The indications that one is suffering from metallosis include pain and inflammation within the affected area, rash or redness and difficulty of movement.
Some medical expert says that the accumulated metal particles in the body may also cause cancer, and cardiac or neurological disorder. To know more about related cases, check the DePuy Recall News Center at www.hiprecallnewscenter.com
DePuy Hip Recall
Vaginal and bladder mesh devices have been marketed with significant benefits to women suffering from severe cases of POP and SUI, medical experts say. However, an increasing number of patients, whose lives have been greatly affected by complications from the use of these implants, have been reportedly seeking the assistance of a bladder sling recall attorney in their legal course.
It did not take long until 1999 that the first major device maker of surgical meshes reached the decision pulling their products off the market because of safety concerns linked to their device. Boston Scientific, the creator of Protegen Vaginal Sling reportedly removed the product from the market in 1999, and recalled their Pinnacle Pelvic Floor Repair Kit in 2011, due to high failure rates and mechanical reasons, respectively.
Sales of ObTape, a vaginal sling which was released into the market in 2003 by Mentor Corporation, was also reportedly discontinued in 2006. Ethicon, a J&J’s unit, has also expressed their decision to end sales of their Prolift, Prolift+ M, TVT Secur and Prosima vaginal meshes, which is anticipated to fully halt at the first quarter of 2013.
When a person has already developed osteoarthritis, there is a tendency for the person to experience unbearable pains on the affected joints. One of the factors why osteoarthritis-stricken patients rely on surgical procedure is to get rid of the source of the pain and replace it with an artificial device such as the DePuy ASR hip implants. Unfortunately,it is facing about 8,000 DePuy hip lawsuits after being reported as defective.
The susceptibility of women to be diagnosed with osteoporosis or stress fracture risk may be mitigated by adequate vitamin D supplementation, medical experts say, citing a new evidence from a recent study. This further evidence that adds potential benefits to the sunshine vitamin which may also minimize potential risks from osteoporosis treatment, such as, Fosamax-related atypical fractures resulting in class action litigations.
The study authors noted that girls who had a large intake of vitamin D on average had a 51 percent higher chance of avoiding stress fractures compared to girls with lower average intakes. This independent finding supports the evidence shown by other studies conducted from the Institute of Medicine and others published on the Archives of Pediatrics & Adolescent Medicine.
Researchers noted that among the 6,712 pre-adolescent and adolescent girls who participated in the seven year study, about 3.9 percent developed stress fractures, particularly those who had a low average vitamin D intake.
While it was noted that dairy and calcium intake did not influence overall resistance to osteoporosis, osteopenia, and fractures, vitamin D was associated with significant decrease in fracture risk.
Numerous medical reports from Zoloft patients, in addition to research studies, consistently show that the drug may bring more harm than benefits. The US Food and Drug Administration (FDA) has released several public health advisories saying that Zoloft side effects may increase suicidal thoughts and behavior, and may also cause birth defects to babies.
Other reported Zoloft side effects include sexual dysfunction, psychosis, delusion, hallucination, memory loss, sleeping problems, eating disorders, abnormal personality changes, unusual mood shifts, irritability, hostility, self-harm and other acts of violence.
People battling depression should know that these side effects can severely affect themselves and their families as well. Thus, a professional medical guidance is needed in treating depression.
For Florida resident Jaimie Simon, who filed a Stryker hip recall lawsuit in the Circuit Court of Broward County, Florida on September 4, 2012, he has had enough. He is now seeking a Stryker hip settlement for injuries he suffered after implantation with the Stryker Rejuvenate hip device.
According to Simon, he went through total hip replacement surgery on his right hip on September 12, 2011. He was implanted with the Stryker Rejuvenate hip device.
After the surgery, the plaintiff claims he suffered significant discomfort in the area of the implant. His hip muscles and bones were corroded by the devices, which had to be removed by surgery, the lawsuit says. Both also had tumor-like formations near the device.
Blood testing further revealed the presence of heavy metal ion contamination. Because of these findings, Simon went through revision surgery on September 10, 2012. During the surgery, fretting and corrosion of the device was confirmed, as was the presence of a large pseudo tumor.
Post-marketing reports, however, indicated that the metal stem and neck components were wearing against one another and depositing tiny shards of metal ions into the surrounding tissue of the joint. This metallic contamination might then cause inflammation, pseudo-tumors, tissue death, and implant failure.
Sertraline, more popularly known by its brand name Zoloft, is an antidepressant drug normally prescribed for the treatment of depression and certain mental health disorders, medical experts say. As it has reportedly emerged as one of the most widely prescribed antidepressants in the United States, it has also been reported to cause certain adverse effects in babies, instigating a series of injury lawsuits due to Zoloft birth defects from some mothers who may have taken the antidepressant during pregnancy.
Despite the risk of side effects from psychiatric medications, the consequences of forgoing depression treatment may just be as potentially detrimental, according to medical experts. A new study may uphold such notion as its findings reveal that babies born to mothers who had untreated depression demonstrated delayed ability in learning their native language. On the other hand, babies whose mothers received drug treatment through commonly prescribed class of antidepressant drugs (selective serotonin reuptake inhibitors or SSRIs) during gestation showed signs of accelerated ability to attune to their native language. Examples of SSRI antidepressants include Prozac, Celexa, and Zoloft.
A total hip replacement is a surgical procedure which removes the diseased hip bone and substitutes it with artificial parts. The Johnson & Johnson was later force to prompt the DePuy hip replacement recall due to the data that about 12 percent of ASR patients had to have to undergo a corrective surgery due to its product’s higher-than-normal failure rate in 2010. However, there are other risks factors that may bring about hip replacement’s high failure rate, and one of those is the reactions of smoking cigarettes after hip replacement surgery, health professionals say.
The possibility of developing blood clots in the lower extremities are high, after hip replacement procedure. These blood clots may potentially reach to the lungs. The prospect of developing blood clots is higher if a hip replacement patient smokes. Smoking decreases the amount of oxygen that reaches the cells in your surgical wound. A potential risk of infection may occur due to the wound’s slow healing process. Smokers may also suffer from heart and lung problems. Your body, heart and lungs are still at risk even if hip replacement goes smoothly.
Osteoporosis is widely alleviated with alendronate sodium generic called Fosamax, a classification of the bisphosphonate drug. Because of the gathered information relating critical bisphosphoonate side effects, Fosamax lawsuit claim is increasing some states. Several claims affirmed by the patients are about the experience of pain and strange complication of the jaw bones. Even if Fosamax seems to be effective with most of the patients, it is beneficial to be conscious of the dangers being linked with bisphosphonates.
Osteonecrosis is an uncommon disease exhibiting pain and apparent swelling of the bone.A large number of individuals are cancer patients who went through chemotherapy are noted to have also acquired osteonecrosis.It is important to note that bisphosphonate is also expended in metastasizing cancer cells in the bones.
Fosamax as an oral variant of bisphosphonates prescribed for osteoporosis is believed to have caused the mentioned osteonecrosis side effect.News records observed osteonecrosis to be evident right after a patient prescribed with Fosamax have undergone dental operation.
Before having any dental treatments, it is important to ask for your physician’s advice about your Fosamax prescription.Another option is for you complete your tooth procedures ahead and only take bisphosphonate after all endodontic concerns are clear.
Stryker, an orthopaedic implant manufacturer, voluntarily pulled out from the market two modular-neck hip stems last July 6, 2012. These are the Rejuvenate Modular and the ABG II modular-neck hip stems. Before the recall, the company released an urgent safety alert in April 2012 which discussed about the probable bad effects of their hip implants. Court charges may be filed against the company, legal specialists say. In fact, the first lawsuit was filed on August 8, 2012 in New Jersey Superior Court, Bergen County. Potential plaintiffs may refer to www.strykerhipreplacementlawsuit.net for legal guidance and more information on Stryker hip recall.
About 20,000 of the recalled implants were sold in the United States. The U.S. Food and Drug Administration (FDA) has collected more than 60 adverse reports on the Stryker devices, reports say.
The FDA released a statement saying that Stryker recalled the implants after the release of a post-market surveillance outcomes. The data showed a high risk of “fretting and/or corrosion” which may lead to tissue damages and metallosis. Metallosis is due to the presence of metal parts in the body’s bloodstream. It may lead to hip joint damage, bone failure, pseudotumors and pain.
The drug Aromasin (exemestane) is used primarily to treat breast cancer in women but it has been found to cause bone density loss which may lead to potential risk of fractures, experts speculate, given findings from a recent study.
This recent research finds that when taking this drug the risk of cancer in post-menopausal women who have tested for hormone-receptor-positive breast cancer is reduced by 65 percent. However, another study finding suggests that this same cancer fighting drug may worsen the risk of bone fractures by as much as three-times.
Exemestane, which is a third-generation aromastase inhibitor, is thought to cause bone loss by inhibiting the hormone estrogen which is essential in maintaining bone health. In women who are at high risk for fractures they should try other medications for breast cancer such as tamoxifen, which is not as effective a breast cancer preventing drug but has actually been found to improve bone density.
In case you need more articles on osteoporosis and medications that affect bone health, you may find more updates and information on the Fosamax class action lawsuit blog.
Based on a data released by the Disabled World, problems with mobility devices are escalating. The number of individuals who have been injured while using mobility devices has doubled in the past 10 years. More than 100,000 Americans were affected while using scooter, walker, cane or wheelchair in 2008.
Particularly in old age, hip problems are one of the most common reason why mobility problems start. Some afflicted patients are prescribed with permanent hip pain treatment like an invasive surgical procedure. However, the DePuy hip recall center features the risks behind hip surgeries because of problems with hip implant devices. With approximately 93,000 recipients worldwide, the DePuy hip replacement system were recalled after data revealed that the devices fail prematurely in one out of eight people who have them.
Osteoporosis and heart disease are two different age-related ailments that have been linked to a substantial rate of incidence, disability, and deaths especially among ageing men and women, medical researchers say. While both health conditions were both regarded as non-related in the past, mounting scientific evidence have reportedly emerged, affirming the connection between both chronic illnesses.
Early studies show how low bone density in osteoporotic post-menopausal women — especially those who are not receiving any treatment — may contribute to an increased calcium buildup on the walls of the arteries of the heart, which in turn raises their risk of a future coronary event such as myocardial infarction, or commonly known as heart attack.
While there are several natural alternatives in dealing with rapid bone loss in older women and men, osteoporosis drugs known as bisphosphonates have been most commonly utilized, medical experts say. However, certain side effects such as dental problems, and spontaneous fractures have been linked to these bone-sparing drugs including Fosamax. The Fosamax Lawsuit Help Center bears related information regarding these adverse events and related legal claims.
While depression may be improved by proper food consumption, eating junk foods may increase its risk, medical experts say, citing recent medical studies. Fast food like pizza, doughnuts and hamburgers are only a few of the foods that are frequently consumed by those who are always busy at work or school. For this reason researchers advise the public to eat more fruits, vegetables and fish, and less on food that has little nutritional value and often high in fat, sugar, and calories. These healthy foods are not only good in protecting against depression but may also reduce the risk of other diseases. There may be more information at http://www.zoloftlawsuithelpcenter.com.